World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02253667
Date of registration: 28/09/2014
Prospective Registration: No
Primary sponsor: Hospital Sao Joao
Public title: Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
Scientific title: Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Patients: a Randomized Controlled Trial
Date of first enrolment: September 2014
Target sample size: 0
Recruitment status: Withdrawn
URL:  https://clinicaltrials.gov/show/NCT02253667
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Portugal
Contacts
Name:     Miguel R Gonçalves, PhD
Address: 
Telephone:
Email:
Affiliation:  Pulmonology Department, University Hospital São João
Key inclusion & exclusion criteria

Inclusion Criteria:

- Consecutive patients who had end-stage lung disease (lung cancer, pulmonary fibrosis,
COPD, …) - (McCabe score > 3 [<6 months life expectancy] and a Palliative Prognostic
Index score = 4) admitted to hospital because of acute respiratory failure and
distress

- Had chosen to forego all life support and receiving only palliative care

- Severe hypoxemia (PaO2/FiO2< 250)

- At least one of the following: dyspnoea (Borg scale =4), signs of respiratory
distress, and respiratory rate greater than 30 beats per min

Exclusion Criteria:

- Patients had to be competent (Kelly score <4)

- Refusal of treatment

- Weak cough reflex

- Agitation or non-cooperation

- Uncontrolled cardiac ischemia or arrhythmias

- Failure of more than two organs

- Use of opioids within the past 2 weeks

- Adverse reactions to opioids

- History of substance misuse

- Known contraindication for morphine (acute renal failure and recent head injury)



Age minimum: 21 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Acute Respiratory Distress Syndrome
Lung Disease
Intervention(s)
Device: HFONC
Device: Conventional oxygen therapy
Primary Outcome(s)
Opioids [Time Frame: 2 days]
Dyspnoea [Time Frame: 2 days]
Secondary Outcome(s)
Patient comfort [Time Frame: 2 days]
Mortality [Time Frame: 6 months]
Physiologic variables [Time Frame: 2 days]
Secondary ID(s)
PalliativeHFONC
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history